Featured Content
The FDA is proposing to withdraw the liquid formulation of simvastatin, known as FloLipid, from the market after Salerno Pharmaceuticals…
The FDA is proposing to withdraw the liquid formulation of simvastatin, known as FloLipid, from the market after Salerno Pharmaceuticals…